期刊文献+

Androgens and estrogens in skeletal sexual dimorphism 被引量:4

【特刊综述】骨骼两性异形中的雄激素和雌激素
下载PDF
导出
摘要 Bone is an endocrine tissue expressing androgen and estrogen receptors as well as steroid metabolizing enzymes. The bioactivity of circulating sex steroids is modulated by sex hormone-binding globulin and local conversion in bone tissue, for example, from testosterone (T) to estradiol (E2) by aromatase, or to dihydrotestosterone by 5(x-reductase enzymes. Our understanding of the structural basis for gender differences in bone strength has advanced considerably over recent years due to increasing use of (high resolution) peripheral computed tomography. These microarchitectural insights form the basis to understand sex steroid influences on male peak bone mass and turnover in cortical vs trabecular bone. Recent studies using Cre/LoxP technology have further refined our mechanistic insights from global knockout mice into the direct contributions of sex steroids and their respective nuclear receptors in osteoblasts, osteoclasts, osteocytes, and other cells to male osteoporosis. At the same time, these studies have reinforced the notion that androgen and estrogen deficiency have both direct and pleiotropic effects via interaction with, for example, insulin-like growth factor 1, inflammation, oxidative stress, central nervous system control of bone metabolism, adaptation to mechanical loading, etc., This review will summarize recent advances on these issues in the field of sex steroid actions in male bone homeostasis. Bone is an endocrine tissue expressing androgen and estrogen receptors as well as steroid metabolizing enzymes. The bioactivity of circulating sex steroids is modulated by sex hormone-binding globulin and local conversion in bone tissue, for example, from testosterone (T) to estradiol (E2) by aromatase, or to dihydrotestosterone by 5(x-reductase enzymes. Our understanding of the structural basis for gender differences in bone strength has advanced considerably over recent years due to increasing use of (high resolution) peripheral computed tomography. These microarchitectural insights form the basis to understand sex steroid influences on male peak bone mass and turnover in cortical vs trabecular bone. Recent studies using Cre/LoxP technology have further refined our mechanistic insights from global knockout mice into the direct contributions of sex steroids and their respective nuclear receptors in osteoblasts, osteoclasts, osteocytes, and other cells to male osteoporosis. At the same time, these studies have reinforced the notion that androgen and estrogen deficiency have both direct and pleiotropic effects via interaction with, for example, insulin-like growth factor 1, inflammation, oxidative stress, central nervous system control of bone metabolism, adaptation to mechanical loading, etc., This review will summarize recent advances on these issues in the field of sex steroid actions in male bone homeostasis.
出处 《Asian Journal of Andrology》 SCIE CAS CSCD 2014年第2期213-222,I0008,共11页 亚洲男性学杂志(英文版)
关键词 androgen receptor bone mineral density ESTRADIOL estrogen receptor male OSTEOBLAST OSTEOCLAST OSTEOCYTE osteoporosis sex hormone-binding globulin testosterone androgen receptor bone mineral density estradiol estrogen receptor male osteoblast osteoclast osteocyte osteoporosis sex hormone-binding globulin testosterone
  • 相关文献

参考文献189

  • 1Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, et al. Androgens and bone. Endocr Rev 2004, 25: 389-425.
  • 2Laurent M, Gielen E, Claessens F, Boonen S, Vandersehueren D. Osteoporosis in older men: recent advances in pathophysiology and treatment. Best Pract Res Clin Endocrinol Metab 2013, 27: 527-39.
  • 3Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006, 17: 1726-33.
  • 4Kanis Ja, Oden A, Mccloskey EV, Johansson H, Wahl DA, et al. IOF Working Group on Epidemiology and Quality of Life. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 2012, 23: 2239-56.
  • 5Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007, 22: 465-75.
  • 6Tarride JE, Guo N, Hopkins R, Leslie WD, Morin S, etal. The burden of illness of osteoporosis in Canadian men. J Bone Miner Res 2012, 27: 2830-8.
  • 7Tarride JE, Hopkins RB, Leslie WD, Morin S, Adachi JD, etal. The burden of illness of osteoporosis in Canada. Osteoporos Int 2012, 23: 2591-600.
  • 8Frost M, Wraae K, Abrahamsen B, Hoiberg M, Hagen C, et al. Osteoporosis and vertebral fractures in men aged 60-74 years. Age Ageing 2012, 41: 171-7.
  • 9Nurmi-Luthje I, Sund R, Juntunen M, Luthje P. Post-hip fracture use of prescribed calcium plus vitamin d or vitamin d supplements and antiosteoporotic drugs is associated with lower mortality: a nationwide study in Finland. J Bone Miner Res 2011, 26: 1845-53.
  • 10Wastesson JW, Ringback Weitoft G, Parker MG, Johnell K, educational level and use of osteoporosis drugs in elderly men and women: a Swedish nationwide register-based study. Osteoporos Int 2013, 24: 433-42.

同被引文献22

引证文献4

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部